D-0077-2023 Class II Terminated
FDA drug recall D-0077-2023 was initiated by RemedyRepack Inc. on Dec 5, 2022 and is designated Class II. Reason for recall: Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency. The recall status is terminated (terminated Feb 3, 2023). Affected quantity: 9 boxes.
Recall Details
- Product Type
- Drugs
- Report Date
- Dec 14, 2022
- Initiation Date
- Dec 5, 2022
- Termination Date
- Feb 3, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9 boxes
Product Description
Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816; Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC #: 70518-3493-00.
Reason for Recall
Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.
Distribution Pattern
Product was distributed to two different customers in MI.
Code Information
Lot # B1817019-082222, Exp. 02/24/2023; B1819127-082322, Exp. 02/26/2023
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0077-2023
- openFDA file date
- Oct 23, 2026
- Loaded by RegDataLab
- Oct 24, 2026